Paper18802153
Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.
Dieu-Nosjean MC and 12 others. J Clin Oncol, 2008. Cited by 828 papers, by iCite.
Cite this record
ConductScience Library. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. Papers, record 18802153. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18802153
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Choristoma | Major topic |
| Lung Neoplasms | Major topic |
| Lymph Nodes | Major topic |
| Adult | |
| Aged | |
| Biopsy | |
| CD4 Lymphocyte Count | |
| Cell Count | |
| Female | |
| Humans | |
| Immunohistochemistry | |
| Male | |
| Middle Aged | |
| Neoplasm Staging | |
| Precancerous Conditions | |
| Prognosis | |
| Retrospective Studies | |
| Survival Rate | |
| T-Lymphocyte Subsets |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 18802146 | Ectopic lymph nodes within human solid tumors. | https://conductscience.org/library/papers/18802146 |
Source PubMed
Cited by587
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 828 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42947476 | Identification of a Glycosylation-Related Gene Prognostic Signature for Non-Small Cell Lung Cancer. | J Gene Med | 2026 | https://conductscience.org/library/papers/42947476 | PubMed |
| 42903730 | Spatial and maturational characterisation of tertiary lymphoid structures predicts immunotherapy response in extensive-stage small cell lung cancer. | Clin Transl Immunology | 2026 | https://conductscience.org/library/papers/42903730 | PubMed |
| 42898662 | From density to spatial function: spatial multi-omics, composite biomarker design, and therapeutic engineering of tertiary lymphoid structures in solid tumors. | Front Immunol | 2026 | https://conductscience.org/library/papers/42898662 | PubMed |
| 42858224 | CD8⁺ T Cell infiltration and spatial organization in cancer: mechanisms, barriers, and therapeutic strategies. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42858224 | PubMed |
| 42828165 | Metabolite-driven dysfunction of intratumoral tertiary lymphoid structures: single-cell and spatial omics perspectives on cancer immune escape. | Front Immunol | 2026 | https://conductscience.org/library/papers/42828165 | PubMed |
| 42787593 | Tertiary lymphoid structures in neoadjuvant and perioperative cancer immunotherapy: a review and proposed framework for biomarker interpretation and validation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42787593 | PubMed |
| 42761275 | Role of Tertiary Lymphoid Structures in Autoimmune Diseases and Cancer. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42761275 | PubMed |
| 42738358 | Bronchoscopic Ablation and Intratumoral Therapies for Lung Cancer: Expanding Local Treatment Beyond Surgical Resection. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738358 | PubMed |
| 42693308 | Tertiary lymphoid structures in cancer: their development, composition, clinical prognosis, and the drivers of the anti-tumor responses. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42693308 | PubMed |
| 42613326 | Humoral immunity in cancer. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42613326 | PubMed |
| 42598915 | TLS as Predictors and Targets in Neoadjuvant Chemoimmunotherapy for NSCLC. | Thorac Cancer | 2026 | https://conductscience.org/library/papers/42598915 | PubMed |
| 42566543 | Formation of tertiary lymphoid structures drives Parkin antitumor immunity. | Sci Adv | 2026 | https://conductscience.org/library/papers/42566543 | PubMed |
| 42548652 | Mechanisms of T cell-mediated antitumor immunity within tertiary lymphoid structures. | Front Immunol | 2026 | https://conductscience.org/library/papers/42548652 | PubMed |
| 42468992 | Spatial architecture of tertiary lymphoid structures represents an independent prognostic dimension in hepatocellular carcinoma. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42468992 | PubMed |
| 42452880 | Tertiary lymphoid structures in gastrointestinal cancer: orchestrating tumour microenvironmental immune subcycles to elegantly amplify the cancer immunity cycle. | Ann Med | 2026 | https://conductscience.org/library/papers/42452880 | PubMed |
| 42449683 | Spatial Transcriptomics of Immune Cell Distribution in Non-Small Cell Lung Cancer Identifies Tertiary Lymphoid Structures and Its Density and Area Fraction Were Associated with Neoadjuvant Therapy Response. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449683 | PubMed |
| 42449297 | The Ki-67 proliferation index in tertiary lymphoid structures as a predictor of survival outcomes in patients with resectable non-small cell lung cancer. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42449297 | PubMed |
| 42444407 | Single-Cell and Spatial Analysis Reveal the Differences Between Left-Sided and Right-Sided Colorectal Cancer. | Cell Prolif | 2026 | https://conductscience.org/library/papers/42444407 | PubMed |
| 42350046 | FLT3L-secreting cDC1 in situ vaccination enhances antitumor immunity and synergizes with PD-1 blockade in murine non-small cell lung cancer. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42350046 | PubMed |
| 42324542 | Prognostic value of tertiary lymphoid structures in locally advanced esophageal squamous cell carcinoma treated with neoadjuvant chemoimmunotherapy: a retrospective study. | J Cardiothorac Surg | 2026 | https://conductscience.org/library/papers/42324542 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| TBX21 | 30009 | PubTator's text mining | https://conductscience.org/library/genes/30009 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18802153
GET https://conductscience.org/api/papers/v1/18802153/cited_by?page=2